bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2023.03.16.533010

Mechanism of defibrillation of cardiac tissue by periodic low-energy pacing

Buran, P.·Niedermayer, T.·Baer, M.
View original source ↗Export metadata ↓

Abstract

Rotating excitation waves and electrical turbulence in excitable cardiac tissue are associated with arrhythmias such as life-threatening ventricular fibrillation. Experimental studies (S. Luther et al., Nature 475, 235-239 (2011)). have shown that a time-periodic sequence of low-energy electrical far-field pulses is able to terminate fibrillation more gently than a single high-energy pulse. During this so called low-energy antifibrillation pacing (LEAP), only tissue near sufficiently large conduction heterogeneities, such as large coronary arteries, is activated. Based on extensive simulations and simple theoretical reasoning, we present a comprehensive unified mechanism for successful LEAP in two spatial dimensional systems, which is able to explain both the termination of stable spirals and of spatiotemporal chaos. We carried out extensive simulations (more than 500000 runs for each considered model) varying pacing periods, pacing field strength and initial conditions using a model of cardiac tissue perforated by blood vessels, which was found earlier to reproduce the behavior seen in the LEAP experiments for different dynamical regimes and different cellular models (P. Buran et al., Chaos 27, 113110 (2017) and New J. Phys. 24 083024 (2022)). We studied altogether three different cellular models to capture qualitatively different kinds of fibrillatory states like stable spirals and spatiotemporal chaos. To achieve a mechanistic understanding of the simulation results, we have investigated a variety of macroscopic observables characterizing an excitable medium with respect to their correlation with the success of an individual low-energy pulse during LEAP. We found in all considered cases that the refractory boundary length LRB, the total length of the borders between refractory and excitable parts of the tissue, displays the strongest correlation with the success of the pacing and thus predicts best the success of an individual LEAP pulse. Furthermore, we found the success probability PL decays exponentially with this length according to PL = exp(- k(E)LRB), where E is the strength of the electrical field in pacing and k(E) is a monotonically decreasing function of E. A closer look at the spatiotemporal dynamics in the simulations reveals that actually each pulse during LEAP annihilates practically all defects and excitation fronts, however, also induces new pairs of defects and associated excitation fronts at the refractory boundaries. The success probability of each individual pulse can thus be simply interpreted as the probability that no new rotor pair gets created by the shock, while all existing defects get annihilated. This assumption allows to derive the observed exponential dependence of the success probability on the refractory boundary length, where the prefactor k(E) in the exponent is equal (for stable spirals) or proportional (for spatiotemporal chaos) to the probability{lambda} (E) that a new rotor pairs is created by the shock along a segment of unit length along the refractory boundary. Our findings are in conformity with the upper limit of vulnerability (ULV) hypothesis, which states that the single pulse defibrillation threshold is simply given by the lowest field strength, where no new rotor pairs arise as a result of the shock. LEAP operates at field strengths (and energies) below this ULV limit. Successful LEAP protocols are characterized by a coordinated interplay between the pulses, that gradually decreases the refractory boundary length and therefore simultaneously increases the success probability until complete defibrillation is achieved.

Explore related subjects

biophysicsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Buran, P., Niedermayer, T., Baer, M.. 2023-03-20. Mechanism of defibrillation of cardiac tissue by periodic low-energy pacing. https://doi.org/10.1101/2023.03.16.533010

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Mechanism of molecular recognition revealed through dynamic drug binding pathways to SARS-CoV-2 main protease

Characterization of drug-binding pathways remains experimentally limited by transient intermediates and computationally challenging due to long timescales intractable for conventional molecular dynamics. To address these challenges, we combined solution NMR titrations with weighted ensemble (WE) enhanced sampling simulations to resolve atomistic pathways of nirmatrelvir binding to the SARS-CoV-2 main protease. NMR titration revealed residue-dependent heterogeneity spanning fast, intermediate, and slow exchange regimes. WE simulations complement the NMR by providing insights into unassigned residues and adding time-resolved and three-dimensional structural context. We map key interactions along two distinct binding pathways, provide dynamic explanations for residues involved in resistance, and capture unique backbone conformations compared to those sampled in unbound or bound states. Our comprehensive binding model is consistent with a combined conformational selection and induced fit mechanism in which early transient contacts are made with residues E47 and L50 and allosteric motions are centered around residue V204 of the distal domain. This synergistic application of WE and titration NMR enables a more comprehensive characterization of drug binding than either method alone, providing an integrated framework that may have broader applicability to defining structure-kinetic relationships and guiding design of next-generation inhibitors.

biophysics↗
bioRxiv2026

Discriminating betacoronavirus receptor usage across subgenera using protein structure prediction and molecular dynamics

A critical step in the emergence of a virus is the ability of the viral protein to bind a host receptor and mediate cell entry. For many coronaviruses, this interaction occurs between the Spike S1 subunit and the human ACE2 receptor. Whether this binding interface can be computationally distinguished across unstudied viruses without experimentally resolved protein structures remains an open question. We predicted how 28 emerging coronaviruses may bind to human ACE2 using structural predictions, static interaction prediction programs, and molecular dynamics simulations. To screen the emerging coronaviruses, we predicted a library of S1 structures using AlphaFold. These predicted structures were then used to model the S1-ACE2 interaction with AlphaFold, ClusPro, and HADDOCK. We used known ACE2-binding sarbecoviruses as positive controls and coronaviruses that bind other receptors as negative controls to threshold predicted binding. Contact analysis quantified the predicted binding and revealed that these static interaction prediction methods varied in discriminative power. Less restrained static predictions separated binders from non-binders, whereas heavily restrained docking did not, potentially forcing an interaction where none should exist. This analysis highlighted an emerging coronavirus, Zhejiang2013, as a potential ACE2 binder. We used molecular dynamics simulations to further assess the static predictions and model the interaction over time. Overall, our results indicate that Zhejiang2013 exhibits dynamic interaction patterns consistent with ACE2 binding. Given that two ACE2-binding coronaviruses have caused global pandemics within the past two decades, identifying potential ACE2 binders is critical for early warning and pandemic preparedness.

biophysics↗
bioRxiv2026

De novo design of flexible protein interactions with GuideFlip

De novo design of protein binders requires a target structure. However, for flexible targets, such as intrinsically disordered proteins, this structure does not exist until the binder has stabilized the interaction. Such targets are therefore difficult for methods that separate structure generation from sequence design. We introduce GuideFlip, which co-designs structure and sequence through guided discrete flow matching: binder residues are assigned progressively while the complex is re-predicted at each step, allowing the evolving interface to affect the design process. GuideFlip reduces the hydrophobic bias of direct AlphaFold optimization and improves in silico success rates over existing approaches. We release a database of binder candidates for 177 human disordered proteins. Experimentally, we obtain de novo binders to the C-terminus of -synuclein and the disordered amino terminus of RBX1 with hit rates of 13.5% and 41.7%, respectively, and we confirm the epitopes of selected binders by NMR and mutagenesis. Applying GuideFlip to flexibility on the binder side, we design a nanobody that binds the agonist-bound {beta}1-adrenergic receptor in the active state, but not the receptor in its inactive state, with a 75% hit rate and cryo-EM structure confirming the design. GuideFlip enables protein design where bound structures emerge only upon binding.

biophysics↗